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ABSTRACT 
Objective: This study was undertaken to investigate the hepatoprotective and antioxidant activity of Quercus ilex leaves extract (QILE) on ethanol-
induced toxicity in Wistar rats.  
Methods: Hepatotoxicity was induced by administering ethanol (40%) at a dose of 7.9 gm/kg/day; p. o. (1:1 of ethanol in olive oil) for 28 d. 
Silymarin 100 mg/kg/day; p. o. was used as a standard drug. The whole study was divided into a prophylactic and curative study. In the 
prophylactic study, the Silymarin and QILE (test drug) 100, 200, and 400 mg/kg Body Weight(BW) given orally one hour before administration of 
40% ethanol administration for 28 d. In the curative study, 7 d of treatment of Silymarin and QILE 200 and 400 mg/kg BW was given orally after 28 
d of ethanol administration to different groups. 
Results: Hepatoprotectivity was confirmed by the highly significantly (p<0.001) restoration of elevated biochemical parameters like SGPT, SGOT, 
ALP, TB, and highly significantly (p<0.001) depleted Albumin and Total protein levels by 200 mg/kg BW QILE in comparison to the positive control 
group. QILE 200 mg/kg highly significantly (p<0.001) raised the antioxidants by draining the elevated oxidative stress markers in comparison of 
positive control group. At dose levels QILE 200 mg/kg, significant (p<0.05) protection from loss in body weight and in liver weight was found when 
the comparison was done with the positive control group. Histopathology revealed that QILE 200 mg/kg reduced the markers of cell necrosis.  
Conclusion: Present study revealed that Quercus ilex leaves have antioxidant and hepatoprotective activity due to its chemical constituents. 
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INTRODUCTION 
“The preservation of health is easier than the cure of disease,” the 
famous words of BJ Palmer, Developer of Chiropractic. Health 
preservation is done by including lots of useful herbs in our meal. 
The presence of a huge variety of herbs in nature shifted the focus of 
scientist to herbal therapeutic interventions instead of chemical 
components which are prone toward hazardous effects. Hepatic 
diseases have become one of the major causes of morbidity and 
mortality due to alcohol abuse over the counter drugs other 
toxicants. All these make the liver vulnerable to a variety of 
disorders such as hepatitis, cirrhosis and jaundice [1]. 
In India, Quercus ilex (Family: Fagaceae, Common name-Holly oak, 
Holm oak) is distributed in inner arid tracts of Himalayas from Satluj 
valley westward and in Kashmir and Himachal Pradesh, Manipal, at 
the attitude of 900-2600 meters [2] and along the Balkan Peninsula, 
North Spain and West France [3]. 
Quercus ilex is one of the most commonly used plants in Morocco to 
treat gastrointestinal disorders and skin infections [4]. The bark of 
Quercus ilex is used in decoction or as a powder, alone or mixed with 
Punicagranatum and Ceratonia silica to treat stomachache [5]. It is 
also used to treat throat infection, hemorrhages, and dysentery. It is 
reported that the Ethyl acetate, butanol and aqueous extracts [6] 
and methanol extracts of Quercus ilex leaves from Turkey [7] possess 
antibacterial activity. Quercus ilex leaves are a rich source of 
polyacylated flavonoids [8]. 
It is traditionally used as Anti-inflammatory,, Cirrhosis, Conjunctivitis, 
Enterocolitis, Gastroenterosis, Gout, Hepatosis, Immunodepression, 
Psoriasis, Rheumatism, Splenosis, Uterosis, Tonsilosis, Nephrosis, 
Enterosis, Breast Cancer, Colon Cancer, Intestine Cancer, Liver cancer, 
Kidney Stone, Cold cough, Dysentery, Vaginosis [9]. 
With the presence of chemical constituents and traditional 
background, the present study was carried out to investigate 
antioxidant and hepatoprotective activity of ethanol extract of 
Quercus ilex leaves by assaying various antioxidant enzymes and 
serum marker enzymes in ethanol intoxicated female rats. 
MATERIALS AND METHODS 
Plant material and extract preparation 
The leaves of Quercus ilex were collected from the Kinnor district of 
Himachal Pradesh in India and authenticated by Himalayan Forest 
Research Institute, Conifer Campus, Panthaghati, Shimla (authentication 
No. DD27014) dated 16/8/12 by Dr. Vaneet Jishtu. The leaves of 
Quercus ilex dried in the shade and coarsely powdered. The defatting of 
leaves was done by a Soxhlet apparatus with petroleum ether. Then 
extraction of defatted powdered leaves was done by using 95% ethanol. 
The extract was drying in Rota Evaporator at 45 °C. The dried extract 
stored in the Vaccum desiccator during the study. 
Drug and chemicals 
Silymarin received as a gift from Ranbaxy Laboratories, Delhi, India. 
Thiobarbituric acid (TBA), 5, 5’-dithiobis (2-nitrobenzoic acid)–
(DTNB), DPPH purchased from Himedia Laboratories, Mumbai, India. 
Malondialdehyde (MDA) obtained from Sigma Chemicals Company, St 
Louis, MO, USA. All other chemicals and reagents were purchased 
commercially by local vendors and were of analytical grade. 
Preparation of test and standard drug 
Ethanol (7.9 g/kg/day) was diluted up to 40%, making a solution of 
1:1 of ethanol in olive oil [10]. The test drug dissolved in lukewarm 
water. Silymarin 100 mg/kg/day; p. o. was administered as a 
suspension in a 1% aqueous solution of carboxymethyl cellulose. 
Acute oral toxicity study 
Acute toxicity is involved in the estimation of LD50 (the dose which 
has proved to be lethal to 50% of the tested group of animals). 
International Journal of Pharmacy and Pharmaceutical Sciences 
Print ISSN: 2656-0097 | Online ISSN: 0975-1491                            Vol 12, Issue 4, 2020 
Malik et al. 
Int J Pharm Pharm Sci, Vol 12, Issue 4, 26-31 
27 
Female Wistar rats (n=3) were randomly selected and kept fasting 
overnight [11]. The crude ethanol extract of quercus ilex leaves was 
administered to the different rats in doses of 500, 1000 and 3000 
mg/kg BW, respectively. The rats were observed for physiological 
changes due to toxicity such as weakness, feed withdrawal, 
dizziness, vomiting, and mortality for 14 d.  
Experimental animals 
Adult female Wistar rats (180-200, 6 wks) purchased from CPCSEA 
approved registered breeder. The animals brought to animal house to 
acclimatize in new environment for 7 d before start of experiments 
and housed under standard laboratory conditions with 23±1 °C 
temperature, 55±10% relative humidity, 12/12 h light/dark cycles, in 
propylene cages, and fed with standard pellet diet from Ashirwad 
Industry and purified water ad libitum [10]. The experimental protocol 
was approved for hepatoprotective activity by the Institution Animal 
Ethics Committee (Reg No. 724/PO/a/02/CPCSEA) with protocol No 
ASCB/IAEC/05/12/071 on dated. 
Experimental procedure 
After acclimatization of 6-7 d, animals were randomly divided into 9 
groups of six each. A total of 54 rats was divided into nine groups of 
6 rats each. The study was performed in two phases that are the 
prophylactic phase and the curative phase.  
• Group 1 received only the saline (1 ml/kg/day; p. o.) served as 
the control group. 
• Group 2 received 40% ethanol 7.9 g/kg/day (1:1 of ethanol in 
olive oil) [10] orally for 28 d and served as the positive control group. 
Prophylactic study 
• Group 3 received silymarin 100 mg/kg orally one hour before 
40% ethanol administration 7.9 g/kg/day (1:1 of ethanol in olive oil) 
for 28 d. 
• Groups 4th, 5th, 6th were administered QILE 100, 200, and 400 
mg/kg BW orally (decided as per acute oral toxicity study) 
respectively one hour before administration of 40% ethanol 
administration 7.9g/kg/day (1:1 of ethanol in olive oil) for 28 d. 
Curative study 
• Group 7 received silymarin 100 mg/kg orally for 7days after 28 
d of ethanol administration. 
• Groups 8th, 9th were received seven days of treatment of QILE 
200 and 400 mg/kg BW orally, respectively, after 28 d of ethanol 
administration. 
All rats were sacrificed by cervical dislocation after 24 h of the last 
treatment. Blood was collected before sacrifice, under mild 
chloroform anesthesia from the retro-orbital sinus plexus. The 
serum was separated from collected blood at 3000 rpm for 15 min 
and used for the determination of marker enzymes (AST, ALP, ALT), 
albumin, total protein, total bilirubin. 
The livers were dissected immediately, washed with ice-cold saline, and 
divided into two equal parts. One part was used for histopathological 
study after fixed in 10% (w/v) buffered formalin, and other for the 
assays of antioxidant enzymes GSH, CAT, and lipid peroxidation. 
Marker enzyme assays 
The liver marker enzymes AST, ALT, and ALP were assayed in serum 
by IFCC method using standard kits supplied from Span Diagnostics 
(Surat, India). The results were expressed as IU/l. 
Protein determination 
The levels of TP and Alb were determined in the serum of 
experimental animals by using the Lowry method and the 
bromocresol green method, respectively [12]. Kits purchased from 
Span Diagnostics (Surat, India) for Alb assay. 
Total Bilirubin estimation  
Total Bilirubin was estimated by measuring the absorbance of 
colored azobilirubin at 546 nm and directly proportional to the total 
bilirubin concentration in the sample [13].  
Lipid peroxidation and antioxidant enzyme activity 
The rats were sacrificed, and their livers excised, rinsed in ice-cold 
normal saline followed by 0.15 M Tris-HCl (pH 7.4) blotted dry and 
weighed. The estimation of lipid peroxidation by the method of 
Ohkawa [14] after preparation of 10% w/v of homogenate prepared 
in 0.15 M Tris-HCl buffer. A part of homogenate was used for the 
estimation of glutathione by the method of Ellman [15] after 
precipitating proteins. The rest of the homogenate was centrifuged 
at 4 °C for 15 min at 15000 rpm. The supernatant thus obtained was 
used for the estimation of CAT activities was measured by the 
method of Aebi [16]. 
Histopathology 
The isolated livers were fixed in a 10% formalin solution and 
dehydrated by using ethanol. Dehydrated liver pieces were 
embedded in paraffin to become hard. Solid liver pieces were 
sectioned with a thickness of 5-6 μm and then stained with eosin 
and hematoxylin. These sections examined for histoarchitectural 
changes under a light microscope [17]. 
Statistical analysis 
The data were expressed as mean±SEM. Statistical differences at 
p<0.05 between the groups were analyzed by one-way ANOVA 
followed by Turkey’s multiple comparison tests using Graph Pad 
Prism software package. 
RESULTS 
Yield value of the extract 
The 17.2% total yield of Quercus ilex leaves extract. Dried extract 
stored in vacuum desiccators containing anhydrous silica gel. 
Acute oral toxicity study of QILE 
Determine the maximum safe dose of QILE by acute oral toxicity 
studies in rats at 2000 mg/kg, followed by OECD guidelines. On the 
bases of observations, it is evident that there is no reduction in 
alertness, spontaneous motor activity, reactivity to sound and 
touch, body, and limb tone. Respiration, urination, pupil size, 
reflexes (pineal, corneal, righting) were found normal for all 14 d 
of study. 
 
Table 1: Animal weight (g) with the time of treatment 
Group Initial body wt. (g) Final body wt. (g) 
Control 249.5±3.40 268.0±3.89b (↑) 
Positive control 255.7±7.61 236.8±10.66β (↓) 
Silymarin (Prophylactic) 253.2±4.75 258.5±4.37a (↑) 
QILE 100 (Prophylactic) 268.8±6.80α 260.7±6.01 (↓) 
QILE 200 (Prophylactic) 250.2±3.91 253.2±4.19 (↑) 
QILE 400 (Prophylactic) 254.7±4.01 255.5±4.93 (↑) 
Silymarin (Curative) 253.8±6.34 256.5±6.35a (↑) 
QILE 200 (Curative) 250.8±2.50 252.5±1.87 (↑) 
QILE 400 (Curative) 247.2±8.55α 248.0±8.09 (↑) 
Value mean±SEM, (n=6) symbols represent statistical significance. αp<0.05, βp<0.01 Vs Control,ap<0.05, bp<0.01 Vs Positive Control One way ANOVA 
followed by Tukey’s Multiple Comparison test. 
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Bodyweight 
One does not notice a significant difference between the weights of 
the animals of the positive control group and the test group (p>0.05) 
from the first day of the treatment. However, there should have been 
an increment in the weight of the animal as per the processing time 
expressed in the week. But in positive control group animals, a 
decrease in weight was observed after four weeks in comparison to 
control group animals. Treatment with QILE restored the weight 
loss in animals in comparison to the control group. At dose levels 
QILE 200 and 400 mg/kg, significant protection from loss in body 
weight in both curative and prophylactic treatments. The results are 
consigned through table 1. 
Liver weight 
A highly significantly (p<0.001) increase in liver weight of ethanol 
intoxicated positive control group animals than in normal saline-
treated control group (table 2). 
Prophylactic treatment of 28 d with silymarin and QILE 200 
restored the inclined level of liver weight highly significantly when a 
comparison was done with the intoxicated positive control group 
and highly significantly than the saline-treated control group. When 
the curative study was done for seven days, silymarin, QILE 200, and 
QILE 400 showed non-significant (p<0.05) and (p<0.01) results 
when compared with a saline-treated control group and highly 
significantly than the intoxicated positive control group. 
 
Table 2: Animal liver weight (g) with the time of treatment 
Groups Liver wt./100g 
Control 2.94±0.06c 
Positive control  4.04±0.09 γz 
Silymarin (Prophylactic) 3.14±0.03c 
QILE 100 (Prophylactic)  3.70±0.04γaz 
QILE 200 (Prophylactic) 3.22±0.02c 
QILE 400 (Prophylactic)  3.27±0.06αc 
Silymarin (Curative) 3.21±0.02c 
QILE 200 (Curative)  3.28±0.08αc 
QILE 400 (Curative)  3.34±0.08βc 
Value mean±SEM, (n=6) symbols represent statistical significance. αp<0.05, βp<0.01 and γp<0.001 Vs Control, ap<0.05, bp<0.01 and cp<0.001 Vs 
Positive Control, xp<0.05, yp<0.01 and zp<0.001 Vs Standard Silymarin. One way ANOVA followed by Tukey’s multiple comparison test. 
 
Effect on serum biochemical parameters 
The impact of QILE on serum marker enzymes SGOT, SGPT, ALP, 
Albumin, Total Protein, and Total bilirubin (TB) summarized in table 
3. A significant (p<0.001) elevation in serum SGOT, SGPT, ALP, and 
TB observed in animals intoxicated with ethanol i.e., positive control 
group (PC) when compared with normal saline-treated animals 
group i.e., control group. During 28 d prophylactic treatment, serum 
level of SGOT, SGPT, ALP, and TB were highly significantly (p<0.001) 
decreased in silymarin and three selected dose levels of QILE (100, 
200 and 400 mg/kg) treated groups when compared to the positive 
control group. When the results of the above serum enzymes level 
were compared to normal saline-treated group, effects of silymarin 
and QILE 200 mg/kg were non-significant, QILE 100 mg/kg highly 
significantly (p<0.001) and QILE 400 mg/kg significantly (p<0.05). 
After 28 d of intoxication with ethanol, seven days curative 
treatment of silymarin, QILE 200, and 400 mg/kg showed a highly 
significant (p<0.001) decline in serum level of SGOT, SGPT, ALP and 
TB in comparison to intoxicated animals. Silymarin, QILE 200 and 
400 mg/kg revealed a non-significant, significant (p<0.05) and 
(p<0.01), respectively, when the comparison was made with the 
control group. 
TP and albumin levels in serum decline highly significantly 
(p<0.001) in ethanol intoxicated positive control group animals in 
comparison to normal saline-treated control group animals. In 
prophylactic treatment, Silymarin, QILE significantly decrease the 
elevated levels of serum TP, and albumin content in ethanol 
intoxicated positive control group animals when the comparison 
was made with positive control group animals. QILE 100 and 400 
mg/kg dose levels restored highly significantly (p<0.001) and 
(p<0.05), respectively the elevated level of serum TP and albumin 
content while Silymarin and QILE 200 mg/kg showed non-
significant result when the comparison was done with the normal 
saline-treated control group. During curative treatment, silymarin 
and QILE (200 and 400 mg/kg) revealed a significant elevation in 
serum TP and albumin content when the comparison was done with 
positive control group animals and showed a non-significant, 
(p<0.05) and (p<0.01) respectively compared with control group 
animals.
  
Table 3: Hepatoprotective evaluation of QILE on serum parameters 
Groups SGPT/AST SGOT/ALT ALP Total Protein Albumin T. B. 
Control group 146.7±3.85c 59.43±2.19c 178.6±4.05c 9.66±0.18c 6.12±0.07c 0.39±0.02c 
Positive control 248.2±4.14γz 108.6±3.04γz 319.8±3.10γz 3.93±0.11γz 3.35±0.09γz 4.1±0.04γz 
Prophylactic study 
Silymarin+Alcohol 152.9±5.46c 62.42±3.54c 189.7±3.74c 9.34±0.22c 5.92±0.12c 0.46±0.02c 
QILE 100+Alcohol 179.4±1.89γcz 82.83±1.71γcz 230.3±4.30γcz 7.73±0.16γcz 4.60±0.08γcz 1.89±0.06 γcz 
QILE 200+Alcohol 158.7±2.98c 66.25±2.88c 192.9±3.79c 9.07±0.06c 5.64±0.14c 0.53±0.01c 
QILE 400+Alcohol 163.4±1.83αc 72.25±0.81αc 196.5±4.40αc 8.91±0.04αc 5.49±0.14βc 0.59±0.01βc 
Curative study 
Silymarin+Alcohol 157.01±2.05c 68.05±1.55c 190.0±5.05c 9.2±0.14c 5.7±0.11c 0.48±0.01c 
QILE 200+Alcohol 160.3±1.87αc 69.84±1.46αc 199.1±2.21αc 8.98±0.05αc 5.46±0.11αc 0.54±0.02βc 
QILE 400+Alcohol 164.5±1.31βc 70.75±1.81βc 203.30±2.04βc 8.77±0.16βc 5.34±0.24βc 0.69±0.02γcz 
Value mean±SEM, (n=6) symbols represent statistical significance. αP<0.05, βP<0.01 and γP<0.001 Vs Control,cP<0.001 Vs Positive Control,zP<0.001 Vs 
Standard Silymarin. One way ANOVA followed by Tukey’s Multiple Comparison test. SGPT/AST-Serum Glutamate Pyruvic Transaminase/Aspartate 
Transaminase, SGOT/ALT-Serum Glutamate Oxaloacetate Transaminase/Alanine Transaminase, ALP-Alkaline Phosphatase, T. B.-Total bilirubin 
 
Histopathological studies 
The liver of animals of the control group showed normal histology. 
The liver section of the intoxicated ethanol group showed a marked 
degree of fatty changes. A high degree of infiltration of inflammatory 
cells, especially neutrophils, was seen within all zones. Inclusion in 
cytoplasm (Mallory bodies) formation also observed at a high level. 
Many hepatocytes showed degenerative changes. Compared with 
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the fatty changes observed in intoxicated ethanol animals, fat 
deposition in the silymarin treated group was much milder degree. 
Mild stromal inflammatory infiltration comprising neutrophils, 
lymphocytes, and macrophages were also seen within the periportal 
and focal midzone area. Regeneration of cells was observed in the 
silymarin group. The livers in the QILE 100 group showed a 
moderate degree of inflammatory cell infiltration within all zones 
leads to mild fatty changes and regeneration of few cells. QILE 200 
mg/kg slight degree of inflammatory cell infiltrations within all 
zones, and many regenerative cells also noticed. Histo-architecture 
of QILE 200 treated rats tended to be more usual compared to QILE 
400, while silymarin treated rats showed almost normal histology. 
 
 
Fig. 1: Representative photomicrographs of liver sections, Group I: Liver section of normal rats showing central vein surrounded by 
hepatic cord of cells (normal architecture). Group II: liver section of alcohol treated rats showing massive fatty changes (b), mallory body 
formation (c), infilteration of neutrophils (a), prolifration of Kupffer cells. Group III: In silymarin treated group liver section showing 
regenerative changes in hepatocytes and minimal inflammatory changes. Group IV: In QILE 100 mg/kg treated group, liver section 
showing marked fatty changes, ballooning degeneration, infilteration if inflammatory cells around central vein. Group V: In QILE 200 
mg/kg treated group, liver section showing mild fatty changes and regeneration of hepatocytes. Group VI: In QILE 400 mg/kg treated 
group, modrate fatty changes, infilteration of inflammatory cells. Group VII: In silymarin 100 mg/kg curative group, liver section showing 
regenerative changes in hepatocytes and minimal inflammatory change. Group VIII: In QILE 200 mg/kg curative group, liver section 
showing mild fatty changes and regeneration of hepatocytes. Group IX: In QILE 400 mg/kg curative group, liver section showing modrate 
fatty changes and regeneration of hepatocytes 
 
DISCUSSION 
The liver plays a significant role in the metabolism of various 
nutrients, detoxification of many endogenous and exogenous 
compounds. There are many xenobiotics and toxicants which affect 
liver functions and damage. Ethanol is one of the liver toxicants, which 
can damage the liver on chronic use. 80% of ethanol is metabolized by 
the liver via various metabolic pathways. Management of ethanolic 
liver diseases is still a challenge to modern medicine. Conventional 
drugs used in the treatment of ethanolic liver diseases are often 
inadequate. Natural plant products have been the main source of 
treatment for many ailment including liver diseases for centuries, with 
about 80 % of the population in poor resource areas currently 
depending on traditional medicine for their primary health care [18]. 
Ethanol is metabolized by the gastric ethanol dehydrogenase and 
converts into acetaldehyde. Aldehyde oxidase or xanthine oxidase 
oxidizes acetaldehyde to acetate by via cytochrome P450 2E1, 
catalase [19]. Ethanol gives rise to the state of oxidative stress by 
depleting the various antioxidant enzymes. Besides, ethanol also 
decreases ATP production by damaging the mitochondria [20, 21]. 
Ethanol induces oxygen deficiency by utilizing more oxygen in its 
metabolism, which amplifies the ROS production and prone the 
hepatocytes toward lipid peroxidation. Ethanol consumption 
increases the level of gut-derived endotoxin to the portal circulation. 
In response to endotoxins, kupffer cells are activated. Activated 
kupffer cells enhance the secretion of proinflammatory cytokines 
and suppress anti-inflammatory cytokine secretion. This results 
inflammation of hepatocytes and causes cell damage [22]. 
The acute oral toxicity study revealed that the absence of lethality 
among the tested animals when administration of QILE as a single 
dose (2000 mg/kg). There was no sign of any gross changes except 
sedation for one to two hr indicating the safe use of the extract. 
Present study explored the in vivo antioxidant and hepatoprotective of 
Quercus ilex leaves extract in both prophylactic and curative condition. 
QILE was administered with olive oil (1:1). It has been reported that 
high fat ethanol diet provokes the development of liver lesions. With 
this model, sustained high ethanol levels were obtained and 
progressive stetosis was accampained by the development of foccal 
inflammation and necrosis [23], especially when a diet rich in 
polyunsaturated fatty acids was used [24, 11],  
All selected dose levels showed a significant hepatoprotection by 
preventing the elevation of transaminase, alkaline phosphatase, and 
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bilirubin levels as compared to intoxicated ethanol animals. These 
are the potent biomarkers of hepatotoxicity. Ethanol treatment 
causes cell necrosis in the liver, leakage of all these enzymes in the 
blood [25]. Decreased the level of total protein and albumin content 
in QILE treated animals reflects the hepatoprotective activity of 
extract as compared to ethanol-treated animals. The elevation in the 
total protein (TP) and albumin is demonstrating the initial damage 
produced in ethanol-treated animals due to leakage of nitrogenous 
substances (non-protein and protein) on destruction of cells; this 
leads to impairment in protein synthesis and it transamination [26]. 
The current study indicates that ethanol exaggerates lipid 
peroxidation. The increase in the MDA level in ethanol-treated liver 
exhibits enhanced peroxidation leading to tissue damage and failure 
of antioxidant mechanisms to prevent the formation of excessive 
free radicals [27]. Oral administration of QILE significantly reverses 
these changes, suggesting a protective effect. 
QILE treatment also demonstrated its antioxidant activity by relieving 
the cell from oxidative stress by decreasing the lipid peroxidation 
insult and maintains the glutathione level, catalase activity, indicating 
the protection of hepatocytic cell membrane structural integrity or 
damaged liver cells regeneration. Glutathione and catalase are the first 
line of cellular defense enzymes and act as free radical scavenging 
enzymes. These enzymes dispose of O2 and H2O2 before their 
interaction to form the more harmful hydroxyl (OH·) radical [28]. 
Reduced glutathione is one of the most abundant non-enzymatic 
antioxidant bio-molecules present in tissues [29]. QILE treatment 
revealed a significant increase in catalase activity and glutathione 
levels in rats as compared to intoxicated rats (table 4). 
Concerning the effect of the extracts on the body weight of the rats, 
the results consigned in table 1. There is a relation between the 
outcome of the extracts, the bodyweight of the rats, and the duration 
of the treatment. Studies reported that weight is a significant and 
straightforward index of toxicity after exposure to toxic substances. 
Statistical studies revealed that there is a weak significant difference 
in the profit of body weight in a group of ethanol-treated animals for 
four weeks as compared to control group animals. The result also 
indicates an increase in animal weight according to the treatment 
period. The lesser gain in body weight seen in ethanol-treated 
animals, affects food utilization or increase in calories loss. The 
reduction in the weight in the rat is the direct result of the signs of 
affection of the liver caused by ethanol [30]. 
Our study revealed that the weight of the liver significantly increases 
in ethanol-treated animals as compared to the control group. QILE 
treatment substantially prevents the elevation in liver weight in 
ethanol animals (table 2). Ethanol intake exhibits the fat 
accumulation in the liver by increase the hepatic production of fatty 
acid, triglyceride, and decreases hepatic fatty acid oxidation leads to 
fatty liver. In fatty liver, impaired filtration of neutrophils and 
lipoprotein [30] enhances the liver volume. QILE treatment prevents 
an increase in liver weight by inhibiting fat deposition in the liver. 
We carried out prophylactic and curative treatment of QILE on 
intoxicated ethanol animals. Our data revealed that QILE 200 mg/kg 
dose showed more antioxidant and hepatoprotective effects in 
comparison to QILE 100 and 400 mg/kg. Twenty-eight days of 
prophylactic treatment is more effective than seven days of curative 
treatment. 
Histopathological study revealed that QILE treatment decreases the 
fat deposition; prevent Mallory body formation, neutrophils 
infiltrations in liver cells as compared to ethanol-treated animals 
(fig. 1). 
Phytoconstituents like the flavonoids, triterpenoids, and glycosides 
[31] are confirmed in Quercus ilex. Phytochemical screening revealed 
that ethanol extract of Quercus ilex leaves contains active 
pharmacological constituents such as flavonoids, alkaloids, 
triterpenoids, and phenolic compounds. However, it has already 
been reported that such phytoconstituents like phenolic compounds, 
flavonoids, tannins [32] are known to possess hepatoprotective 
activity in various experimental models. Kaempferol, ellagic acid, 
gallic acid, catechin, quercetin present in Quercus ilex leaves 
revealed antioxidant and hepatoprotective activity, which is being 
also confirmed by the biochemical and histological parameters.  
CONCLUSION  
Quercus ilex is an enriching plant in flavonoids, triterpenoids, 
glycosides, ascorbic acid. Due to all these constituents, it shows 
antioxidant activity. Our study revealed its antioxidant and 
hepatoprotective activity. From future aspects, due to its antioxidant 
activity, it can be used in various diseases like diabetes, 
inflammatory diseases, and neuronal disorders etc. causes oxidative 
stress. Further phytochemical study or isolation of principle active 
constituents from Quercus ilex may give rise to the evaluation of 
various pharmacological activities. 
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